R‐CP CHEMOIMMUNOTHERAPY IN PATIENTS WITH IGM PARAPROTEINAEMIC NEUROPATHY PRODUCES IMPROVEMENTS IN FUNCTIONAL, ELECTROPHYSIOLOGICAL AND SEROLOGICAL OUTCOMES. (June 2017) - Duncombe, A.S.; Colchester, N.; Allen, D.; Katifi, H.